942618-26-0

Basic information

• Product Name: (R)-3-(2-METHOXYETHOXY)PYRROLIDINE
• Synonyms: (R)-3-(2-METHOXYETHOXY)PYRROLIDINE;(3R)-3-(2-Methoxyethoxy)pyrrolidine;(R)-3-(2-Methoxy-ethoxy)-pyrrolidine HCl
• CAS NO: 942618-26-0
• Molecular Formula: C₇H₁₅NO₂
• Molecular Weight: 145.2
• Mol File: 942618-26-0.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 197.6°C at 760 mmHg
• Flash Point: 73.5°C
• Appearance: /
• Density: 0.98g/cm³
• Vapor Pressure: 0.376mmHg at 25°C
• Refractive Index: 1.45
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: (R)-3-(2-METHOXYETHOXY)PYRROLIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-3-(2-METHOXYETHOXY)PYRROLIDINE(942618-26-0)
• EPA Substance Registry System: (R)-3-(2-METHOXYETHOXY)PYRROLIDINE(942618-26-0)

Safety Data

• Hazardous Substances Data: 942618-26-0(Hazardous Substances Data)

Usage

General Description

(R)-3-(2-METHOXYETHOXY)PYRROLIDINE is a chemical compound with the molecular formula C8H17NO2. It is a pyrrolidine derivative with a methoxyethoxy group attached to the third carbon of the pyrrolidine ring. (R)-3-(2-METHOXYETHOXY)PYRROLIDINE is commonly used as a building block in the synthesis of various organic compounds and pharmaceuticals. It has been studied for its potential use in drug development and has shown promising results in various pharmacological applications. However, further research is needed to fully understand its properties and potential uses in different fields.

InChI:InChI=1/C7H15NO2/c1-9-4-5-10-7-2-3-8-6-7/h7-8H,2-6H2,1H3/t7-/m1/s1

Upstream product

• 1212413-55-2 tert-butyl (R)-3-(2-methoxyethoxy)pyrrolidine-1-carboxylate 

Downstream Products

• 1315585-74-0 (R)-2-(3-(2-Methoxyethoxy)pyrrolidin-1-yl)-N-(4-((4-((5-methyl-1H-pyrazol-3-yl)amino)pyrrolo[2,1-f][1,2,4]triazin-2-yl)thio)phenyl)acetamide 

Relevant articles and documents

4-PYRIDONE COMPOUND OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION AND FORMULATION INCLUDING SAME

An object of the present invention is to provide a compound or a salt thereof having anti-HBV activity, a pharmaceutical composition, an anti-hepatitis B virus agent, a production inhibitor of DNA of a hepatitis B virus, and a production or secretion inhibitor of a hepatitis B surface antigen. According to the present invention, provided are a compound represented by General Formula [1] or a salt thereof: (in the formula, R1 represents a benzothiazolyl group which may be substituted (in which a carbon atom constituting the 6-membered ring of the benzothiazolyl group of R1 is bonded to the nitrogen atom of the pyridone ring); R2 represents a C2-6 alkenyl group which may be substituted, or the like; and R3 represents a hydrogen atom or the like).